{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27398818", "DateCompleted": {"Year": "2017", "Month": "02", "Day": "08"}, "DateRevised": {"Year": "2017", "Month": "02", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "09", "Day": "16"}], "ELocationID": ["10.1111/bcpt.12639"], "Language": ["eng"], "Journal": {"ISSN": "1742-7843", "JournalIssue": {"Volume": "120", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Jan"}}, "Title": "Basic & clinical pharmacology & toxicology", "ISOAbbreviation": "Basic Clin Pharmacol Toxicol"}, "ArticleTitle": "In Vitro Effects of the Neolignan 2,3-Dihydrobenzofuran Against Leishmania Amazonensis.", "Pagination": {"StartPage": "52", "EndPage": "58", "MedlinePgn": "52-58"}, "Abstract": {"AbstractText": ["Leishmaniasis is an infectious disease complex caused by protozoa from the Leishmania genus, which presents a broad spectrum of clinical manifestations: cutaneous, mucocutaneous and visceral forms. The current treatments are unsatisfactory considering that few drugs are available and present some level of toxicity. Many lignans and neolignans have been used for the development of new antileishmania drugs. The capability in\u00a0vitro of the neolignan 2,3-dihydrobenzofuran (2,3-DBF), a commonly found constituent of propolis and other plants, to inhibit the growth of promastigote and macrophage-internalized amastigote forms of Leishmania amazonensis was investigated. The cytotoxicity of this compound was assessed by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) test in BALB/c murine macrophages and human erythrocyte lysis assay. The 2,3-DBF was active against promastigote (IC<sub>50</sub> =1.042\u00a0\u03bcM) and amastigote (IC<sub>50</sub> =1.43\u00a0\u03bcM) forms, indicating a potent antileishmanial effect. There was no evidence of cytotoxicity to macrophages or erythrocytes at concentrations ranging from 13 to 0.5\u00a0\u03bcM, after 48\u00a0hr of exposure. The antileishmanial activity is probably mediated by the activation of macrophages, because treatment with 2,3-DBF increases both phagocytic and lysosomal activities, as well as the nitrite (NO<sub>2</sub><sup>-</sup> ) levels. These results suggest that 2,3-DBF may be a potential candidate for the development of a new promising antileishmanial drug. Further studies are needed to determine its potential in\u00a0vivo effect as well as additional mechanisms underlying the antileishmanial and immunomodulatory activities."], "CopyrightInformation": "\u00a9 2016 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Federal University of Piau\u00ed, Teresina, PI, Brazil."}], "LastName": "de Castro Oliveira", "ForeName": "Luciano Gomes", "Initials": "LG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Federal University of Piau\u00ed, Teresina, PI, Brazil."}], "LastName": "Brito", "ForeName": "Lucas Moreira", "Initials": "LM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Federal University of Piau\u00ed, Teresina, PI, Brazil."}], "LastName": "de Moraes Alves", "ForeName": "Michel Mu\u00e1lem", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Federal University of Piau\u00ed, Teresina, PI, Brazil."}], "LastName": "Amorim", "ForeName": "Layane Val\u00e9ria", "Initials": "LV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Federal University of Piau\u00ed, Teresina, PI, Brazil."}], "LastName": "Sobrinho-J\u00fanior", "ForeName": "Enoque Pereira Costa", "Initials": "EP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Federal University of Piau\u00ed, Teresina, PI, Brazil."}], "LastName": "de Carvalho", "ForeName": "Camila Ernanda Sousa", "Initials": "CE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Federal University of Piau\u00ed, Teresina, PI, Brazil."}], "LastName": "da Franca Rodrigues", "ForeName": "Klinger Antonio", "Initials": "KA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Federal University of Piau\u00ed, Teresina, PI, Brazil."}, {"Identifier": [], "Affiliation": "Department of Biophysics and Physiology, Federal University of Piau\u00ed, Teresina, PI, Brazil."}], "LastName": "Arcanjo", "ForeName": "Daniel Dias Rufino", "Initials": "DD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Federal University of Piau\u00ed, Teresina, PI, Brazil."}], "LastName": "das Gra\u00e7as Lopes Cit\u00f3", "ForeName": "Ant\u00f4nia Maria", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Federal University of Piau\u00ed, Teresina, PI, Brazil."}, {"Identifier": [], "Affiliation": "Department of Biochemistry and Pharmacology, Federal University of Piau\u00ed, Teresina, PI, Brazil."}], "LastName": "de Amorim Carvalho", "ForeName": "Fernando A\u00e9cio", "Initials": "FA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Basic Clin Pharmacol Toxicol", "NlmUniqueID": "101208422", "ISSNLinking": "1742-7835"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiprotozoal Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzofurans"}, {"RegistryNumber": "0", "NameOfSubstance": "Lignans"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["adverse effects", "pharmacology"], "DescriptorName": "Antiprotozoal Agents"}, {"QualifierName": ["adverse effects", "pharmacology"], "DescriptorName": "Benzofurans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Erythrocytes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hemolysis"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Hydroxylation"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": ["drug effects", "growth & development", "physiology"], "DescriptorName": "Leishmania"}, {"QualifierName": ["adverse effects", "pharmacology"], "DescriptorName": "Lignans"}, {"QualifierName": ["drug effects", "enzymology"], "DescriptorName": "Lysosomes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Macrophage Activation"}, {"QualifierName": ["drug effects", "immunology", "metabolism", "parasitology"], "DescriptorName": "Macrophages, Peritoneal"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": ["agonists", "metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": [], "DescriptorName": "Osmolar Concentration"}, {"QualifierName": ["drug effects"], "DescriptorName": "Phagocytosis"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2015", "Month": "6", "Day": "29"}, {"Year": "2016", "Month": "7", "Day": "5"}, {"Year": "2016", "Month": "7", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "7", "Day": "12", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27398818", "10.1111/bcpt.12639"]}}], "PubmedBookArticle": []}